Artigo de Revisão
Stein et al.
Genética e exercício
Arq Bras Cardiol. 2017; 108(3):263-270
1. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all cause
mortality:systematicreviewanddose-responsemeta-analysisofcohortstudies.
Int J Epidemiol. 2011;40(5):1382-400.
2. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S, et al. Incidence
and causes of sudden death in U.S. college athletes. J Am Coll Cardiol.
2014;63(16):1636-43.
3. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et
al; American Heart Association Statistics Committee and Stroke Statistics
Subcommittee.Heartdiseaseandstrokestatistics-2015update:areportfrom
the AmericanHeart Association. Circulation. 2015;131(4):e29-322.
4. MaronBJ,DoererJJ,HaasTS,TierneyDM,MuellerFO.Suddendeathsinyoung
competitiveathletes:analysisof1866deaths intheUnitedStates,1980-2006.
Circulation. 2009;119(8):1085-92.
5. Manonelles Marqueta P, Tapia BA, Boraita Pérez A, Luengo Fernández E,
Beristaina CP, Suárez Mier MP. La muerte súbita en el esporte: registro en el
estado espanol. ApuntsMed Esport. 2007;42(153):26-35.
6. CorradoD,BassoC,PaveiA,MichieliP,SchiavonM,ThieneG.Trendsinsudden
cardiovascular death in young competitive athletes after implementation of a
preparticipation screening program. JAMA. 2006;296(13):1593-601.
7. Harmon KG, Drezner JA, WilsonMG, Sharma S. Incidence of sudden cardiac
death in athletes: a state-of-the-art review. Heart. 2014;100(16):1227-34.
8. Solberg EE, Borjesson M, Sharma S, Papadakis M, WilhelmM, Drezner JA, et
al; Sport Cardiology Section of the EACPR of the ESC. Sudden cardiac arrest
in sports - need for uniform registration: A Position Paper from the Sport
Cardiology Section of the European Association for Cardiovascular Prevention
and Rehabilitation. Eur J Prev Cardiol. 2016;23(6):657-67.
9. RisgaardB,WinkelBG,JabbariR,GlingeC,Ingemann-HansenO,ThomsenJL,
etal.Sports-relatedsuddencardiacdeathinacompetitiveandanoncompetitive
athlete population aged 12 to 49 years: data from an unselected nationwide
study inDenmark. Heart Rhythm. 2014;11(10):1673-81.
10. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity
enhance the risk of sudden death in adolescents and young adults? J Am Coll
Cardiol. 2003;42(11):1959-63.
11. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, et al.
Cardiovascularevaluationofmiddle-aged/seniorindividualsengagedinleisure-
timesportactivities:positionstandfromthesectionsofexercisephysiologyand
sportscardiologyoftheEuropeanAssociationofCardiovascularPreventionand
Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2011;18(3):446-58.
12. Priori SG, Blomström-Lundqvist C, Mazzanti A, BlomN, Borggrefe M, Camm
J, et al. 2015 ESC Guidelines for the management of patients with ventricular
arrhythmiasandthepreventionofsuddencardiacdeath.TheTaskForceforthe
Management of Patients with Ventricular Arrhythmias and the Prevention of
SuddenCardiacDeath of the European Society of Cardiology (ESC); Endorsed
by: Association for European Pediatric and Congenital Cardiology (AEPC). On
behalf of Authors/Task ForceMembers. Eur Heart J. 2015;36(41):2793-867.
13. MonserratL,Ortiz-GengaM,LesendeI,Garcia-GiustinianiD,Barriales-VillaR,
deUna-IglesiasD,etal.GeneticsofCardiomyopathies:NovelPerspectiveswith
Next Generation Sequencing. Curr PharmDes. 2015;21(4):418-30.
14. MaronBJ,RowinEJ,CaseySA,LinkMS,LesserJR,ChanRH,etal.Hypertrophic
cardiomyopathy in adulthood associated with low cardiovascular
mortality with contemporary management strategies. J Am Coll Cardiol.
2015;65(18):1915-28.
15. Smith W; Members of CSANZ Cardiovascular Genetics Working Group.
Guidelines for the diagnosis and management of arrhythmogenic right
ventricular cardiomyopathy. Heart Lung Circ. 2011;20(12):757-60.
16. Cruz FM, Sanz-Rosa D, Roche-Molina M, García-Prieto J, García-Ruiz JM,
Pizarro G, et al. Exercise triggers ARVC phenotype in mice expressing a
disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol.
2015;65(14):1438-50.
17. JamesCA,BhonsaleA,TichnellC,MurrayB,RussellSD,TandriH,etal.Exercise
increases age-related penetrance and arrhythmic risk in arrhythmogenic right
ventricular dysplasia/cardiomyopathy-associated desmosomal mutation
carriers. J AmColl Cardiol. 2013;62(14):1290-7.
18. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et
al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific
triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89-95.
19. Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, et
al. Clinical characterisation and long-term prognosis of women with Brugada
syndrome. Heart. 2016;102(6):452-8.
20. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and disqualification
recommendations for competitive athletes with cardiovascular abnormalities:
task force 10: the cardiac channelopathies. A scientific statement from the
American Heart Association and American College of Cardiology. J Am Coll
Cardiol. 2015;66(21):2424-8.
21. HoffjanS.GeneticdissectionofMarfansyndromeandrelatedconnectivetissue
disorders: an update 2012. Mol Syndromol. 2012;3(2):47-58.
22. Lopes R, Berg-McGraw J. Marfan syndrome in a female collegiate basketball
player: a case report. J Athl Train. 2000;35(1):91-5.
23. Hogan, CJ. An aortic dissection in a young weightlifter with non-Marfan
fibrillinopathy. EmergMed J. 2005;22(4):304-5.
24. Türk UO, Alioğlu E, Nalbantgil S, Nart D.. Catastrophic cardiovascular
consequencesofweight liftinginafamilywithMarfansyndrome.ArchTurkSoc
Cardiol. 2008;36(1):32-4.
25. CassidySB,AllansonJE.Managementofgeneticsyndromes.3
rd
ed.Oxford(UK):
Wiley-Blackwell; 2010. p. 495-516.
26. Kasikcioglu E. Aortic elastic properties in athletes with Marfanoid habitus: the
need for early and accurate diagnosticmethods. Eur Heart J. 2005;26(1):100.
27. RobinsonPN,Arteaga-SolisE,BaldockC,Collod-BéroudG,BoomsP,DePaepe
A,etal.ThemoleculargeneticsofMarfansyndromeandrelateddisorders.JMed
Genet. 2006;43(10):769-87.
28. Tsai SH, Lin YY, Hsu CW, Chen YL, Liao MT, Chu SJ. The characteristics
of acute aortic dissection among young Chinese patients: a comparison
betweenMarfan syndrome and non-Marfan syndrome patients. Yonsei Med
J. 2009;50(2):239-44.
29. Braverman AC, Harris KM, Kovacs RJ, Maron BJ; American Heart Association
Electrocardiography and Arrhythmias Committee of Council on Clinical
Cardiology, Council on Cardiovascular Disease in Young, Council on
Cardiovascular and Stroke Nursing, Council on Functional Genomics
and Translational Biology, and American College of Cardiology. Eligibility
and Disqualification Recommendations for Competitive Athletes With
Cardiovascular Abnormalities: Task Force 7: AorticDiseases, IncludingMarfan
Syndrome: A Scientific Statement From the American Heart Association and
American College of Cardiology. Circulation. 2015;132(22):e303-9.
30. JondeauG,DetaintD,TubachF,ArnoultF,MilleronO,RaouxF,etal.Aorticevent
rateintheMarfanpopulation:acohortstudy.Circulation.2012;125(2):226-32.
31. Pyeritz RE; American College of Medical Genetics and Genomics. Evaluation
oftheadolescentoradultwithsomefeaturesofMarfansyndrome.GenetMed.
2012;14(1):171-7.
32. RichardsS,AzizN,BaleS,BickD,DasS,Gastier-FosterJ,etal;ACMGLaboratory
QualityAssuranceCommittee.Standardsandguidelinesfortheinterpretationof
sequencevariants:ajointconsensusrecommendationoftheAmericanCollege
ofMedicalGeneticsandGenomicsandtheAssociationforMolecularPathology.
Genet Med. 2015;17(5):405-24.
33. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the
European Society of Cardiology Consensus Recommendations RevisitedA
Comparison of U.S. and European Criteria for Eligibility and Disqualification
ofCompetitiveAthletesWithCardiovascularAbnormalities. JAmCollCardiol.
2008;52(24):1990-6.
Referências
270
